Gosset Ownership
Private
Therapeutic Areas
Stage
Phase 3
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Tioga Pharmaceuticals General Information
Tioga Pharmaceuticals is a clinical-stage pharmaceutical company developing asimadoline, a selective kappa-opioid receptor agonist, for the treatment of pruritus and related conditions. The company has focused on women's health and dermatological indications. Asimadoline has been evaluated in multiple clinical trials for its efficacy in reducing itch associated with various conditions[1][2][6].
Contact Information
Website
Primary Industry
Biotech
Corporate Office
San Diego, California
United States
United States
Drug Pipeline
asimadoline
Phase 3Key Partnerships
Tioga Pharmaceuticals Funding
No funding data available
To view Tioga Pharmaceuticals's complete valuation and funding history, request access »